Bylund James 4
4 · REPLIGEN CORP · Filed Feb 26, 2024
Insider Transaction Report
Form 4
REPLIGEN CORPRGEN
Bylund James
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2024-02-23$94.33/sh+940$88,670→ 18,508 total - Sale
Common Stock
2024-02-23$198.08/sh−4,373$866,204→ 14,135 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-23+940→ 4,000 totalExercise: $94.33Exp: 2030-04-01→ Common Stock (940 underlying)
Footnotes (2)
- [F1]$198.08 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.73 to $198.46 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]2,000 shares vest and become exercisable on both 4/1/2024 and 4/1/2025.